Cite
A truncated fragment of Ov-ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length protein.
MLA
Guo, Jingjing, et al. “A Truncated Fragment of Ov-ASP-1 Consisting of the Core Pathogenesis-Related-1 (PR-1) Domain Maintains Adjuvanticity as the Full-Length Protein.” Vaccine, vol. 33, no. 16, Apr. 2015, pp. 1974–80. EBSCOhost, https://doi.org/10.1016/j.vaccine.2015.02.053.
APA
Guo, J., Yang, Y., Xiao, W., Sun, W., Yu, H., Du, L., Lustigman, S., Jiang, S., Kou, Z., & Zhou, Y. (2015). A truncated fragment of Ov-ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length protein. Vaccine, 33(16), 1974–1980. https://doi.org/10.1016/j.vaccine.2015.02.053
Chicago
Guo, Jingjing, Yi Yang, Wenjun Xiao, Weilai Sun, Hong Yu, Lanying Du, Sara Lustigman, Shibo Jiang, Zhihua Kou, and Yusen Zhou. 2015. “A Truncated Fragment of Ov-ASP-1 Consisting of the Core Pathogenesis-Related-1 (PR-1) Domain Maintains Adjuvanticity as the Full-Length Protein.” Vaccine 33 (16): 1974–80. doi:10.1016/j.vaccine.2015.02.053.